94 results on '"Viriato D"'
Search Results
2. PRO131 WHAT DO WE KNOW ABOUT PATIENT'S AND CAREGIVERS' EXPERIENCE WHEN LIVING WITH THE HEREDITARY RETINAL CONDITION RETINITIS PIGMENTOSA?
3. PSS6 WHAT IS THE LIFETIME COST OF BLINDNESS IN PEOPLE WITH RPE65-MEDIATED INHERITED RETINAL DYSTROPHY IN THE UK?
4. PRO148 PSYCHOMETRIC EVALUATION OF A MODIFIED VISUAL FUNCTION QUESTIONNAIRE (MVFQ-25) USING DATA FROM A PHASE III OPEN-LABEL RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH INHERITED RETINAL DYSTROPHY CAUSED BY BIALLELIC RPE65 MUTATIONS
5. CC3 COST-EFFECTIVENESS ANALYSIS OF VORETIGENE NEPARVOVEC VERSUS BEST SUPPORTIVE CARE IN PATIENTS WITH RPE65-MEDIATED INHERITED RETINAL DYSTROPHY: A FRENCH HEALTHCARE SYSTEM PERSPECTIVE
6. PSY28 - EPIDEMIOLOGY OF RPE65 GENE MUTATION RELATED INHERITED RETINAL DYSTROPHIES: A SYSTEMATIC LITERATURE REVIEW
7. PSS66 - IDENTIFYING THE MOST SUITABLE QUALITY OF LIFE ASSESSMENT TOOLS TO MEASURE HUMANISTIC BURDEN OF ACUTE OTITIS MEDIA IN CHILDREN
8. PSY195 - HUMANISTIC BURDEN ASSOCIATED WITH RPE65 GENE MUTATION RELATED INHERITED RETINAL DYSTROPHIES: A SYSTEMATIC LITERATURE REVIEW
9. PSY85 - ECONOMIC BURDEN ASSOCIATED WITH RPE65 GENE RELATED INHERITED RETINAL DYSTROPHIES: A SYSTEMATIC LITERATURE REVIEW
10. PSS67 - UNDERSTANDING THE PATIENT EXPERIENCE OF PRESBYOPIA AND IDENTIFICATION OF PATIENT-REPORTED OUTCOME ASSESSMENTS: A LITERATURE REVIEW
11. Patient Characteristics and Treatment Patterns in Chronic Heart Failure: Results from a Multinational Real-World Cross Sectional Survey
12. Burden of Disease on Chronic Heart Failure Patients: A Multinational Cross-Sectional Survey in Real World Setting
13. A Systematic Review Of Predictive Models In Acute Heart Failure
14. Burden of Chronic Heart Failure on Caregivers: A Multinational Cross-Sectional Survey in Real World Setting
15. How To Ensure An Efficient Resource Allocation For The Treatment of Chronic Myeloid Leukemia
16. Real-World Evidence of Ruxolitinib In The Treatment of Myelofibrosis: Experince of A Portuguese Hospital Center
17. Clinical And Economic Impact of Treatment-Free Interval In Patients With Relapsed/Refractory Multiple Myeloma
18. Disease Mapping And Spatial-Temporal Analysis Of Hospital Admissions Due To Heart Failure In Portugal
19. Real-World Effectiveness of Amlodipine/Valsartan/Hydroclorothiazide Single-Pill Combination in the Treatment of Patients with Essential Hypertension
20. Ranibizumab Vs. Verteporfin Photodynamic Therapy for The Treatment Of Myopic Choroidal Neovascularization: Cost Effectiveness Study In Portugal
21. Real-World Evidence of Iron Chelation Therapy In Transfusion-Dependent Mds Patients: A Portuguese Hospital Registry
22. Dual Bronchodilation With Qva149 In Patients With Severe And Very Severe Copd – Are There Incremental Benefits For Portuguese Patients And For The Portuguese Nhs When Compared With Current Treatment Options In Portugal?
23. Can Qva149 Improve Short Term Outcomes In Patients With Copd Without Increasing The Overall Treatment Costs For The Portuguese Nhs? Optimizing Treatment Outcomes With A Responsible Use Of Limited Resources
24. PCV169 - Patient Characteristics and Treatment Patterns in Chronic Heart Failure: Results from a Multinational Real-World Cross Sectional Survey
25. PRM111 - A Systematic Review Of Predictive Models In Acute Heart Failure
26. PCV127 - Burden of Disease on Chronic Heart Failure Patients: A Multinational Cross-Sectional Survey in Real World Setting
27. PCV126 - Burden of Chronic Heart Failure on Caregivers: A Multinational Cross-Sectional Survey in Real World Setting
28. How To Improve Health Outcomes In the Treatment of Chronic Myeloid Leukemia
29. Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective
30. The Economic Impact of Therapy Optimization in Chronic Obstructive Pulmonary Disease in Portugal
31. PSY47 - How To Ensure An Efficient Resource Allocation For The Treatment of Chronic Myeloid Leukemia
32. PSY46 - Clinical And Economic Impact of Treatment-Free Interval In Patients With Relapsed/Refractory Multiple Myeloma
33. PSY18 - Real-World Evidence of Ruxolitinib In The Treatment of Myelofibrosis: Experince of A Portuguese Hospital Center
34. Impact of Value Communication in Decision Making: An Approach to the Treatment of Type 2 Diabetes in Portugal
35. PCV14 - Real-World Effectiveness of Amlodipine/Valsartan/Hydroclorothiazide Single-Pill Combination in the Treatment of Patients with Essential Hypertension
36. PRS20 - The Economic Impact of Therapy Optimization in Chronic Obstructive Pulmonary Disease in Portugal
37. PSY12 - How To Improve Health Outcomes In the Treatment of Chronic Myeloid Leukemia
38. PND20 - Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective
39. PDB124 - Impact of Value Communication in Decision Making: An Approach to the Treatment of Type 2 Diabetes in Portugal
40. PRS37 - Dual Bronchodilation With Qva149 In Patients With Severe And Very Severe Copd – Are There Incremental Benefits For Portuguese Patients And For The Portuguese Nhs When Compared With Current Treatment Options In Portugal?
41. PRS38 - Can Qva149 Improve Short Term Outcomes In Patients With Copd Without Increasing The Overall Treatment Costs For The Portuguese Nhs? Optimizing Treatment Outcomes With A Responsible Use Of Limited Resources
42. PCV171 - Disease Mapping And Spatial-Temporal Analysis Of Hospital Admissions Due To Heart Failure In Portugal
43. PSS28 - Ranibizumab Vs. Verteporfin Photodynamic Therapy for The Treatment Of Myopic Choroidal Neovascularization: Cost Effectiveness Study In Portugal
44. PSY6 - Real-World Evidence of Iron Chelation Therapy In Transfusion-Dependent Mds Patients: A Portuguese Hospital Registry
45. PND20 Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective
46. PCV171 Disease Mapping And Spatial-Temporal Analysis Of Hospital Admissions Due To Heart Failure In Portugal
47. PSS28 Ranibizumab Vs. Verteporfin Photodynamic Therapy for The Treatment Of Myopic Choroidal Neovascularization: Cost Effectiveness Study In Portugal
48. PRS20 The Economic Impact of Therapy Optimization in Chronic Obstructive Pulmonary Disease in Portugal
49. PSY6 Real-World Evidence of Iron Chelation Therapy In Transfusion-Dependent Mds Patients: A Portuguese Hospital Registry
50. PDB124 Impact of Value Communication in Decision Making: An Approach to the Treatment of Type 2 Diabetes in Portugal
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.